Author Archives: leon

Should India allow Direct-to-consumer pharmaceutical advertising (DTCPA)?

Unethical pharmaceutical advertising practices have for long been a bone of contention for the Government as well as patient right groups. Time and again, the pharmaceutical industry has been accused of adopting questionable practices in relation to the marketing of their products. The main focus of attention in this respect has been suspect interactions between […]

Direct-to-consumer pharmaceutical advertising (DTCPA)?

Direct-to-consumer pharmaceutical advertising (DTCPA) has grown rapidly during the past several decades and is now the most prominent type of health communication that the public encounters. DTCA for pharmaceuticals was legalized in 1997. Despite its relatively short 22-year existence, it has heavily impacted the advertising landscape for U.S. healthcare and stands in stark contrast to […]

Do you know “H2H Marketing Model” was formerly called “Bangalore Model”?

“H2H Marketing Model” was formerly called “Bangalore Model,” as it has been developed by one of the co-authors Prof. Dr. Uwe Sponholz on the campus of Christ University in Bangalore, India. He is a visiting professor at Christ. The model integrates current concepts in the form of a new human-oriented mindset, improved marketing process, and […]

How pharma can amplify design thinking to connect more with consumers

Design thinking is a term used to represent a set of cognitive, strategic and practical processes by which design concepts are developed. Patients are demanding a stronger role in clinical research. They want to feel as though they’re involved in trial planning and the dissemination of results, and they want the trials themselves to be […]

Advertising Digitally for Rare Disease Clinical Trials in the 21st Century

It’s no secret that the Rare Disease Clinical Trials industry is struggling to keep operational costs under control. Between 2008 and 2013, clinical trial costs went up by a full 60%, and Tufts research indicates that the average cost of a new prescription drug approval is now more than $2.6 million. It’s worth pointing out […]

The Future of Tech in Nutraceuticals Industry

A global industry survey conducted by Nutrify Today, a nutraceuticals i2c (ideas to commercialization) platform, has found that there is growing optimism around the food and nutrition industry globally and technologies like artificial intelligence will further drive the market growth. The study also sees India as a leading player in the industry that will harness […]

Blockbuster drugs, building and sustaining billion-dollar brands

A blockbuster drug is a very popular drug that generates annual sales of $1 billion or more for the company that sells it. Common blockbuster drugs are Vioxx, Lipitor, and Zoloft. Blockbuster drugs are used for common ailments, such as diabetes, cholesterol, high blood pressure, and cancer, that many individuals face. Examples in recent years […]

Pharma Marketing: How to Successfully Market in the Pharma Industry

The Market in the Pharma Industry is $900 billion and this figure is fully expected to exceed $1,1 trillions in the next few years. In fact, recent studies show the industry is growing at a rate of 5%, which is just behind the two other major healthcare segments – medical services and equipment. As a […]

Has the pharma industry forgotten the role of Knowledge marketing?

Role of Knowledge marketing is a process whereby companies identify, store, share, and reuse their own data, external information and most important the business knowledge and experience of employees. Knowledge management is not just about technology, but also about implementing new business processes. It’s a fast-paced marketplace out there for pharmaceutical, biotech and medical device […]